S 150
118th Congress
Senate
Health
Administrative remedies
Civil actions and liability
Competition and antitrust
Consumer affairs
Drug safety, medical device, and laboratory regulation
Federal Trade Commission (FTC)
Health care costs and insurance
Inflation and prices
Intellectual property
Judicial review and appeals
Manufacturing
Prescription drugs
Affordable Prescriptions for Patients Act of 2023
Everywhere this bill has been
11 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 15, 2024
Held at the desk.
Jul 15, 2024
Received in the House.
Jul 12, 2024
Message on Senate action sent to the House.
Jul 11, 2024
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S4537-4538)
Jul 11, 2024
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
Jul 11, 2024
Measure laid before Senate by unanimous consent. (consideration: CR S4537-4538)
Mar 1, 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
Mar 1, 2023
Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
Feb 9, 2023
Committee on the Judiciary. Ordered to be reported without amendment favorably.
Jan 30, 2023
Read twice and referred to the Committee on the Judiciary.
Jan 30, 2023
Introduced in Senate
Plain-English summary
Affordable Prescriptions for Patients Act of 2023
This bill limits in certain instances the number of patents that a reference biological product manufacturer can assert in a patent infringement lawsuit against a company seeking to sell a biosimilar version.
Specifically, if the biosimilar manufacturer completes certain actions as part of an abbreviated pathway to get market approval, the bill limits, subject to exceptions and waivers, the number of certain types of patents that the reference product manufacturer may assert, such as patents filed more than four years after the reference product received market approval.
What's happening now
Held at the desk.
Committees of jurisdiction
1